| For: | Zheng S, Li YX, Han TT, Zhang Y, Jiang DD, Hu YM. Systematic review and meta-analysis of Statins-Fibrates therapy in diabetic dyslipidemia patients. World J Meta-Anal 2014; 2(4): 194-203 [DOI: 10.13105/wjma.v2.i4.194] |
|---|---|
| URL: | https://www.wjgnet.com/2308-3840/full/v2/i4/194.htm |
| Number | Citing Articles |
| 1 |
Mohammad Abdullah Al Zubair Naim, Keiichi Sumida, Elani Streja, Fridtjof Thomas, Robert Lowell Davis, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy. Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol. Drugs 2026; doi: 10.1007/s40265-025-02275-w
|
| 2 |
Francisco G. Padilla-Padilla, Lina N. Ruiz-Bernes, Luis M. Román-Pintos, Juan A. Peraza-Zaldívar, José G. Sander-Padilla, Laura A. Lugo-Sánchez, Kevin F. Rios-Brito, María M. Arguedas-Núñez, Diana Flores-Huanosta, Jorge González-Canudas. Efficacy and Safety of the Fixed-Dose Combination of Atorvastatin/Fenofibrate Versus Atorvastatin on the Lipid Profile of Patients with Type 2 Diabetes and Dyslipidemia. Cardiology and Therapy 2025; 14(2): 297 doi: 10.1007/s40119-025-00410-y
|
| 3 |
David Karásek. Combined lipid-lowering therapy. Vnitřní lékařství 2018; 64(12): 1177 doi: 10.36290/vnl.2018.169
|
